IP Library › Granted Patent US 11,098,357
Granted Patent B2
US 11,098,357 · App. 16/743,604 · Granted Aug 24, 2021

Compositions and methods for identification of a duplicate sequencing read

Inventors: Douglas A. Amorese (Los Altos, CA); Jonathan Scolnick (San Francisco, CA); Ben Schroeder (San Mateo, CA)
Assignee: TECAN GENOMICS, INC.
C12Q1/6874C12Q1/6869C12Q2525/179C12Q2525/191
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,098,357
App. No.
16/743,604
Granted
Aug 24, 2021
Kind
B2
Abstract

The present invention provides methods, compositions and kits for detecting duplicate sequencing reads. In some embodiments, the duplicate sequencing reads are removed.

Claims (14)

1. A method for detecting duplicate sequencing reads, the method comprising:

ligating an adaptor to each of a plurality of nucleic acid fragments, wherein each adaptor comprises a unique identifier having from about 1 to about 8 nucleotides, an indexing site unique to a subset of the adaptors, and a primer binding site;

amplifying the adaptor-ligated fragments into amplicons;

sequencing the amplicons to produce sequence reads that include identifier and target sequences; and

identifying sequence reads with identical identifier and target sequences as duplicates.

2. The method of claim 1 , further comprising removing a duplicate read from the sequence reads.

3. The method of claim 1 , wherein the identifier site is sequenced with the target sequence.

4. The method of claim 1 , wherein the identifier site is sequenced separately from the target sequence.

5. The method of claim 1 , wherein the nucleic acid fragments comprise RNA.

6. The method of claim 1 , wherein the nucleic acid fragments are genomic DNA fragments or cDNA fragments.

7. The method of claim 1 , wherein the primer binding site is a universal target sequencing primer binding site.

8. The method of claim 1 , wherein each unique identifier is 6 nucleotides in length.

9. The method of claim 1 , wherein each unique identifier is 8 nucleotides in length.

10. The method of claim 1 , wherein each unique identifier is at a junction between the adapter and the nucleic fragment.

Assignments (3)
CHANGE OF NAME Recorded Jul 20, 2021
From: NUGEN TECHNOLOGIES, INC.
To: TECAN GENOMICS, INC.
Reel/Frame 056918/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2020
From: AMORESE, DOUGLAS; SCHROEDER, BEN; SKOLNICK, JONATHAN
To: NUGEN TECHNOLOGIES, INC.
Reel/Frame 053605/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2020
From: AMORESE, DOUGLAS; SCHROEDER, BEN; SCOLNICK, JONATHAN
To: NUGEN TECHNOLOGIES, INC.
Reel/Frame 052380/0398 →
Continuity (4)
Continuation 15406002 · Jan 13, 2017
Division 14540917 · Nov 13, 2014
Provisional Application 61903826 · Nov 13, 2013
Related Publication 20200239953A1 · Jul 30, 2020
Cited By (2)
US 12,371,732 US 12,630,864